Agios Pharmaceuticals, Inc. (AGIO)

CIK 1439222 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Agios Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Aug 6, 202640001439222-26-000120
Aug 4, 20261440001950047-26-007592
Aug 3, 2026SCHEDULE 13G/A0000908834-26-000367
Jul 30, 20268-K0001439222-26-000115
Jul 30, 202610-Q0001439222-26-000118
Jul 10, 202640001439222-26-000112
Jul 2, 2026SCHEDULE 13G0001104659-26-080304
Jul 2, 202640001439222-26-000110
Jul 1, 20261440001439222-26-000108
Jun 23, 202640001439222-26-000099
Jun 23, 202640001439222-26-000107
Jun 23, 202640001439222-26-000089
Jun 23, 202640001439222-26-000091
Jun 23, 202640001439222-26-000081
Jun 23, 202640001439222-26-000083
Jun 23, 202640001439222-26-000103
Jun 23, 202640001439222-26-000093
Jun 23, 202640001439222-26-000087
Jun 23, 202640001439222-26-000095
Jun 23, 202640001439222-26-000097
Jun 23, 202640001439222-26-000101
Jun 23, 202640001439222-26-000085
Jun 23, 202640001439222-26-000105
Jun 23, 202640001439222-26-000079
Jun 18, 20268-K0001193125-26-275879